RxDoctor Payments Data

Chethan Gangireddy, MD

Clinical Cardiac Electrophysiology · Philadelphia, PANPI 1316108582

Payments from drug & device makers

$69,637in general payments, 2019–2025

Across 131 payments — averaging $531.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$61K
  • Impulse Dynamics (USA) Inc.$4K
  • Medtronic$3K
  • Biosense Webster, Inc.$817
  • Abbott$427
  • Abiomed$160
  • plus $589 from 9 others

What the payments were for

  • Speaking & faculty fees$3,00037%
  • Food & beverage$5,17163%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$69,637 in reported general payments places this provider in the 65th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$67,683
Medicare patients
1,084
Services billed
2,034

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban47$38,547
XareltoRivaroxaban23$18,914
Flecainide Acetate25$526
Propafenone Hcl12$488
SotalolSotalol Hcl15$379
Amiodarone Hcl41$334
Carvedilol26$210
Losartan Potassium15$177
Metoprolol Succinate27$172
Furosemide13$24

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →